133 related articles for article (PubMed ID: 17067304)
1. The effects of adulthood olanzapine treatment on cognitive performance and neurotrophic factor content in male and female rats neonatally treated with quinpirole.
Thacker SK; Perna MK; Ward JJ; Schaefer TL; Williams MT; Kostrzewa RM; Brown RW
Eur J Neurosci; 2006 Oct; 24(7):2075-83. PubMed ID: 17067304
[TBL] [Abstract][Full Text] [Related]
2. Adulthood olanzapine treatment fails to alleviate decreases of ChAT and BDNF RNA expression in rats quinpirole-primed as neonates.
Brown RW; Perna MK; Maple AM; Wilson TD; Miller BE
Brain Res; 2008 Mar; 1200():66-77. PubMed ID: 18289509
[TBL] [Abstract][Full Text] [Related]
3. The effects of adulthood nicotine treatment on D2-mediated behavior and neurotrophins of rats neonatally treated with quinpirole.
Brown RW; Perna MK; Schaefer TL; Williams MT
Synapse; 2006 Apr; 59(5):253-9. PubMed ID: 16408261
[TBL] [Abstract][Full Text] [Related]
4. Adulthood nicotine treatment alleviates behavioural impairments in rats neonatally treated with quinpirole: possible roles of acetylcholine function and neurotrophic factor expression.
Brown RW; Thompson KD; Thompson KN; Ward JJ; Thacker SK; Williams MT; Kostrzewa RM
Eur J Neurosci; 2004 Mar; 19(6):1634-42. PubMed ID: 15066159
[TBL] [Abstract][Full Text] [Related]
5. Neonatal quinpirole treatment impairs Morris water task performance in early postweanling rats: relationship to increases in corticosterone and decreases in neurotrophic factors.
Brown RW; Flanigan TJ; Thompson KN; Thacker SK; Schaefer TL; Williams MT
Biol Psychiatry; 2004 Aug; 56(3):161-8. PubMed ID: 15271584
[TBL] [Abstract][Full Text] [Related]
6. The effects of eticlopride on Morris water task performance in male and female rats neonatally treated with quinpirole.
Brown RW; Thompson KN; Click IA; Best RA; Thacker SK; Perna MK
Psychopharmacology (Berl); 2005 Jul; 180(2):234-40. PubMed ID: 15696328
[TBL] [Abstract][Full Text] [Related]
7. Neonatal quinpirole treatment enhances locomotor activation and dopamine release in the nucleus accumbens core in response to amphetamine treatment in adulthood.
Cope ZA; Huggins KN; Sheppard AB; Noel DM; Roane DS; Brown RW
Synapse; 2010 Apr; 64(4):289-300. PubMed ID: 19953655
[TBL] [Abstract][Full Text] [Related]
8. Ontogenetic quinpirole treatment produces long-lasting decreases in the expression of Rgs9, but increases Rgs17 in the striatum, nucleus accumbens and frontal cortex.
Maple AM; Perna MK; Parlaman JP; Stanwood GD; Brown RW
Eur J Neurosci; 2007 Nov; 26(9):2532-8. PubMed ID: 17970732
[TBL] [Abstract][Full Text] [Related]
9. Nicotine sensitization in adult male and female rats quinpirole-primed as neonates.
Perna MK; Cope ZA; Maple AM; Longacre ID; Correll JA; Brown RW
Psychopharmacology (Berl); 2008 Jul; 199(1):67-75. PubMed ID: 18548235
[TBL] [Abstract][Full Text] [Related]
10. Sex differences in nicotine sensitization and conditioned hyperactivity in adolescent rats neonatally treated with quinpirole: role of D2 and D3 receptor subtypes.
Sheppard B; Lehmann J; Cope ZA; Brown RW
Behav Neurosci; 2009 Dec; 123(6):1296-308. PubMed ID: 20001113
[TBL] [Abstract][Full Text] [Related]
11. Developmental treatment with the dopamine D2/3 agonist quinpirole selectively impairs spatial learning in the Morris water maze.
Vorhees CV; Johnson HL; Burns LN; Williams MT
Neurotoxicol Teratol; 2009; 31(1):1-10. PubMed ID: 18930132
[TBL] [Abstract][Full Text] [Related]
12. Perinatal Treatments with the Dopamine D₂-Receptor Agonist Quinpirole Produces Permanent D₂-Receptor Supersensitization: a Model of Schizophrenia.
Kostrzewa RM; Nowak P; Brus R; Brown RW
Neurochem Res; 2016 Feb; 41(1-2):183-92. PubMed ID: 26547196
[TBL] [Abstract][Full Text] [Related]
13. Adolescent nicotine sensitization and effects of nicotine on accumbal dopamine release in a rodent model of increased dopamine D2 receptor sensitivity.
Perna MK; Brown RW
Behav Brain Res; 2013 Apr; 242():102-9. PubMed ID: 23291224
[TBL] [Abstract][Full Text] [Related]
14. Transgenerational evidence of increases in dopamine D2 receptor sensitivity in rodents: Impact on sensorimotor gating, the behavioral response to nicotine and BDNF.
Gill WD; Burgess KC; Vied C; Brown RW
J Psychopharmacol; 2021 Oct; 35(10):1188-1203. PubMed ID: 34291671
[TBL] [Abstract][Full Text] [Related]
15. Neonatal quinpirole treatment produces prepulse inhibition deficits in adult male and female rats.
Maple AM; Smith KJ; Perna MK; Brown RW
Pharmacol Biochem Behav; 2015 Oct; 137():93-100. PubMed ID: 26296939
[TBL] [Abstract][Full Text] [Related]
16. Dopamine D3 receptors mediate the discriminative stimulus effects of quinpirole in free-feeding rats.
Baladi MG; Newman AH; France CP
J Pharmacol Exp Ther; 2010 Jan; 332(1):308-15. PubMed ID: 19797621
[TBL] [Abstract][Full Text] [Related]
17. Modulation of mGlu5 improves sensorimotor gating deficits in rats neonatally treated with quinpirole through changes in dopamine D2 signaling.
Brown RW; Varnum CG; Wills LJ; Peeters LD; Gass JT
Pharmacol Biochem Behav; 2021 Dec; 211():173292. PubMed ID: 34710401
[TBL] [Abstract][Full Text] [Related]
18. Sex differences in high fat diet-induced impairments to striatal Akt signaling and enhanced sensitivity to the behavioral effects of dopamine D
Ramos J; Hernandez-Casner C; Cruz B; Serafine KM
Physiol Behav; 2019 May; 203():25-32. PubMed ID: 29154786
[TBL] [Abstract][Full Text] [Related]
19. An analysis of nicotine conditioned place conditioning in early postweanling and adolescent rats neonatally treated with quinpirole.
Perna MK; Henderson YO; Bruner CL; Brown RW
Behav Brain Res; 2011 Jun; 220(1):254-61. PubMed ID: 21315765
[TBL] [Abstract][Full Text] [Related]
20. Potentiation of olanzapine substitution in rats discriminating clozapine by the D2/3 agonist quinpirole.
Cole JC; Field M; Sumnall HR; Goudie AJ
Behav Pharmacol; 2007 May; 18(3):185-90. PubMed ID: 17426482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
